q&more
My watch list
my.chemie.de  
Login  

Author

Prof. Dr. Heinfried H. Radeke

Johann Wolfgang Goethe-Universität Frankfurt (Main), Pharmazentrum Frankfurt, Institut für Allgemeine Pharmakologie und Toxikologie

Heinfried H. Radeke studied medicine at the Hannover Medical School (MHH) and received his medical license in 1985. His Ph.D. thesis was recognized as the best research dissertation of 1986. After two years as an assistant physician at the Göttingen University Hospital, he began his career at MHH in 1987 with his research focus: the mechanisms of chronic inflammation in the field of molecular pharmacology. He completed his habilitation in this field in 1993 before further specializing as a consultant for general pharma­cology and toxicology, consultant immunologist (DGfI), and consultant for clinical pharmacology (Frankfurt, 2004).

Following a four-month research project at BASF Bioresearch in Cambridge (Boston) in 1992, Heinfried Radeke spent the period 1994–1997 completing further DFG-sponsored research in the USA. This involved one year at UC San ­Francisco (interleukin-1 alpha and carcinogenesis), followed by two years at Case Western Reserve University in Cleveland (nephritis, differentiation of T cells). Since 2001, Prof. Radeke has been aiding the realignment of pharmazentrum frankfurt (Prof. Josef M. Pfeilschifter, dean of medical faculty and director of the Institute of General Pharmacology and Toxicology) towards immunopharmacology, from 2001 to 2008 as the Dr. Hans Schleussner Foundation Lecturer for Immunopharmacology. He plays a decisive role in the training of medical and dental students, with past positions including that of deputy director of the DFG’s largest research training group, GRK1172 Biologicals, in which over 100 doctorates were awarded from 2005 – 2014.

Facts, background information, dossiers

  • chronic inflammation
  • immunopharmacology

More about Uni Frankfurt am Main

  • News

    How to brew high-value fatty acids with brewer's yeast

    Short-chain fatty acids are high-value constituents of cosmetics, active pharmaceutical ingredients, antimicrobial substances, aromas or soap. To date, it has only been possible to extract them from crude oil by chemical means or from certain plants, such as coconut, using a complex process ... more

    Starship Enterprise concept: Optical tractor beam traps bacteria

    Up to now, if scientists wanted to study blood cells, algae, or bacteria under the microscope, they had to mount these cells on a substrate such as a glass slide. Physicists at Bielefeld and Frankfurt Universities have developed a method that traps biological cells with a laser beam enablin ... more

  • q&more articles

    Why biosimilars and not biogenerics?

    Medicines produced using genetic techniques have existed since 2006, called “similar biological medicinal products” or “biosimilars”. Until a year ago, this was a fairly low-profile group, even in expert circles. This has all changed now, however, with the recent licensing of the first bios ... more

    Paradigm shift

    What would medicine be without drugs? But are these drugs being used optimally today? Not at all, as we now know thanks to the findings of molecular medicine. Because for the use of these drugs, it is important to observe two aspects: the disease and the patient. Only slowly is it becom ... more

    Polar and a potential drinking water hazard

    In Germany, drinking water supplies are plentiful and generally of a high quality. Drinking water is in Germany most commonly produced from groundwater (69.6 %), with a further 12.4 % being taken from lakes and dam reservoirs. The proportion of drinking water processed from bank filtration ... more

  • Authors

    Prof. Dr. Theo Dingermann

    Theodor Dingermann, born 1948, studied pharmacy in Erlangen ­and received his doctor title in 1980 to become Dr. rer. nat. In 1990 he was offered the C4 professorship at the Institute for Pharmaceutical Biology, University of Frankfurt.  From 2000 to 2004 he was President of the German Phar ... more

    Prof. Dr. Wilhelm Püttmann

    Wilhelm Püttmann studied chemistry at RWTH Aachen and the University of Cologne. He received his doctorate in organic synthesis under Professor Emanuel Vogel in Cologne in 1980. Following two years of postdoctoral work, he moved to the field of geochemical analysis, assuming the leadership ... more

q&more – the networking platform for quality excellence in lab and process

The q&more concept is to increase the visibility of recent research and innovative solutions, and support the exchange of knowledge. In the broad spectrum of subjects covered, the focus is on achieving maximum quality in highly innovative sectors. As a modern knowledge platform, q&more offers market participants one-of-a-kind networking opportunities. Cutting-edge research is presented by authors of international repute. Attractively presented in a high-quality context, and published in German and English, the original articles introduce new concepts and highlight unconventional solution strategies.

> more about q&more

q&more is supported by:



Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE